Family history and improving health.

Nadeem Qureshi, Brenda Wilson, Pasqualina Santaguida, Julian Little, June Carroll, Judith Allanson, Parminder Raina
{"title":"Family history and improving health.","authors":"Nadeem Qureshi,&nbsp;Brenda Wilson,&nbsp;Pasqualina Santaguida,&nbsp;Julian Little,&nbsp;June Carroll,&nbsp;Judith Allanson,&nbsp;Parminder Raina","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review aimed to evaluate, within unselected populations: Question 1 (Q1) key elements of family history (FH) which usefully predict subsequent disease; Question 2 (Q2) the accuracy of reporting FH; Question 3 (Q3) the impact of FH-based risk information on the uptake of preventive interventions; Question 4 (Q4) the potential for harms associated with collecting cancer FH; Question 5 (Q5) factors that facilitate or hinder the collection of family history; and, Question 6 (Q6) future directions.</p><p><strong>Data sources: </strong>MEDLINE, EMBASE, CINAHL, Cochrane Controlled Trial Register (CCTR), and PsycINFO were searched from 1995 to March 2, 2009 inclusive.</p><p><strong>Review methods: </strong>Standard systematic review methodology was employed. Eligibility criteria varied by question, but overall, specified studies reported in English, excluded qualitative designs, and limited populations to those unselected for pre-existing risk (except for Q2). Study designs and outcomes varied by research question.</p><p><strong>Results: </strong>One hundred and thirty-seven publications were eligible in total for this review. Q1: Key elements of FH: Eighty-nine studies were eligible for this question of which 59 reported FH and data on subsequent or current disease in subjects. The varied definitions of positive FH were consistently associated with elevated relative risks, but their value in predicting future risk or detecting current disease was difficult to assess without considering further information on other risk factors or the available preventive interventions. Q2: Accuracy of FH Reporting. Thirty-seven studies evaluated accuracy and showed relatively high specificity and low sensitivity across all disease categories. Q3: Uptake of preventive interventions. Two studies evaluated the impact of FH-based risk and the evidence was insufficient to establish any effect on change in clinical preventive behavior or uptake of interventions. Q4: Harms of FH taking. Three studies evaluated the impact of FH-based risk information on psychological outcomes and indicated no evidence of significant harm.Q5: Factors affecting FH collection: The evidence base for addressing Q5 is heterogeneous and limited to six studies exploring the association between various factors and family history reporting, documentation and discussion.</p><p><strong>Conclusions: </strong>Our review indicates: (Q1) Many FH definitions showed low discriminatory accuracy in predicting disease risk in individuals but further research is warranted; (Q2) accuracy of reporting is higher for relatives without, than those affected by, a given disease; (Q3) there is insufficient evidence to assess the effect of FH-based risk assessment on preventive behaviors; (Q4) there is limited evidence to assess whether the provision of FH-based personalized risk assessment results in adverse outcomes; (Q5) there is little evidence on factors affecting FH reporting and collection in primary care.</p>","PeriodicalId":72991,"journal":{"name":"Evidence report/technology assessment","volume":" 186","pages":"1-135"},"PeriodicalIF":0.0000,"publicationDate":"2009-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781392/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence report/technology assessment","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This systematic review aimed to evaluate, within unselected populations: Question 1 (Q1) key elements of family history (FH) which usefully predict subsequent disease; Question 2 (Q2) the accuracy of reporting FH; Question 3 (Q3) the impact of FH-based risk information on the uptake of preventive interventions; Question 4 (Q4) the potential for harms associated with collecting cancer FH; Question 5 (Q5) factors that facilitate or hinder the collection of family history; and, Question 6 (Q6) future directions.

Data sources: MEDLINE, EMBASE, CINAHL, Cochrane Controlled Trial Register (CCTR), and PsycINFO were searched from 1995 to March 2, 2009 inclusive.

Review methods: Standard systematic review methodology was employed. Eligibility criteria varied by question, but overall, specified studies reported in English, excluded qualitative designs, and limited populations to those unselected for pre-existing risk (except for Q2). Study designs and outcomes varied by research question.

Results: One hundred and thirty-seven publications were eligible in total for this review. Q1: Key elements of FH: Eighty-nine studies were eligible for this question of which 59 reported FH and data on subsequent or current disease in subjects. The varied definitions of positive FH were consistently associated with elevated relative risks, but their value in predicting future risk or detecting current disease was difficult to assess without considering further information on other risk factors or the available preventive interventions. Q2: Accuracy of FH Reporting. Thirty-seven studies evaluated accuracy and showed relatively high specificity and low sensitivity across all disease categories. Q3: Uptake of preventive interventions. Two studies evaluated the impact of FH-based risk and the evidence was insufficient to establish any effect on change in clinical preventive behavior or uptake of interventions. Q4: Harms of FH taking. Three studies evaluated the impact of FH-based risk information on psychological outcomes and indicated no evidence of significant harm.Q5: Factors affecting FH collection: The evidence base for addressing Q5 is heterogeneous and limited to six studies exploring the association between various factors and family history reporting, documentation and discussion.

Conclusions: Our review indicates: (Q1) Many FH definitions showed low discriminatory accuracy in predicting disease risk in individuals but further research is warranted; (Q2) accuracy of reporting is higher for relatives without, than those affected by, a given disease; (Q3) there is insufficient evidence to assess the effect of FH-based risk assessment on preventive behaviors; (Q4) there is limited evidence to assess whether the provision of FH-based personalized risk assessment results in adverse outcomes; (Q5) there is little evidence on factors affecting FH reporting and collection in primary care.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
家族史和改善健康状况
目的:本系统综述旨在评估,在未选择的人群中:问题1 (Q1)家族史(FH)的关键因素,有效地预测后续疾病;问题2 (Q2)报告FH的准确性;问题3 (Q3)基于fh的风险信息对采取预防性干预措施的影响;问题4 (Q4)收集癌症FH相关的潜在危害;问题5 (Q5)促进或阻碍家族史收集的因素;问题6 (Q6)未来发展方向。资料来源:检索自1995年至2009年3月2日(含)的MEDLINE、EMBASE、CINAHL、Cochrane对照试验登记册(CCTR)和PsycINFO。评价方法:采用标准的系统评价方法。资格标准因问题而异,但总体而言,以英语报道的特定研究排除了定性设计,并将人群限制在未选择存在风险的人群中(第二季度除外)。研究设计和结果因研究问题而异。结果:共有137篇文献符合本综述的要求。问题1:FH的关键要素:89项研究符合此问题,其中59项研究报告了FH以及受试者随后或当前疾病的数据。FH阳性的不同定义始终与较高的相对风险相关,但如果不考虑其他风险因素的进一步信息或可用的预防干预措施,则难以评估其在预测未来风险或检测当前疾病方面的价值。Q2: FH报告的准确性。37项研究评估了所有疾病类别的准确性,并显示出相对较高的特异性和较低的敏感性。问题3:采取预防性干预措施。两项研究评估了基于fh的风险的影响,但证据不足以确定对临床预防行为或干预措施的改变有任何影响。问题4:服用FH的危害。三项研究评估了基于fh的风险信息对心理结果的影响,没有证据表明存在显著危害。问题5:影响FH收集的因素:解决问题5的证据基础是异构的,仅限于六项研究,探索各种因素与家族史报告、文献和讨论之间的关系。结论:我们的综述表明:(Q1)许多FH定义在预测个体疾病风险方面具有较低的歧视性准确性,但需要进一步研究;(Q2)没有患病的亲属报告的准确性高于那些患病的亲属;(Q3)评估基于fh的风险评估对预防行为的影响的证据不足;(Q4)评估提供基于fh的个性化风险评估是否会导致不良后果的证据有限;几乎没有证据表明影响初级保健中FH报告和收集的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review. Data Linkage Strategies to Advance Youth Suicide Prevention. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. Health Information Exchange. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1